Magazine

Specialized publication dedicated to Good Manufacturing Practice, modernization of pharmaceutical production, and modern pharmaceutical manufacturing technologies

TOP News

Vialek Book Banner

CNS Pharmaceuticals commenced a crowdfunding campaign for its GMB drug

research
Houston-based CNS Pharmaceuticals is combining an unusual financing method with some interesting chemistry to expand the therapeutic choices for glioblastoma (GBM) patients.

ICON will use Intel Pharma Analytics Platform in clinical trials

clinical trials
ICON, a global provider of drug development solutions, agreed on preliminary deal terms with Intel Corporation to enable ICON to offer the Intel Pharma Analytics Platform for use in clinical trials.

MSD start clinical studies of its investigational polyvalent conjugate vaccine

merck
MSD (known as "Merck" in USA and Canada) announced that the company is beginning two Phase 3 studies of PCV-15 (V114), its investigational polyvalent conjugate vaccine for the prevention of pneumococcal disease.

WuXi AppTec launches expanded Laboratory Testing Division in USA

laboratory
WuXi AppTec, a leading global pharmaceutical and medical device company, announced the opening of its expanded Laboratory Testing Division (LTD) facility in New Jersey.

Arcinova obtained Innovate UK grant for its continuous processing technology

lab
British multi-service contract resesearch and development organization Arcinova announced the award of an Innovate UK grant for the development of new flexible modular manufacturing technologies.

FDA approved GW Pharmaceuticals cannabis-based drug Epidiolex

epidiolex
If approved, Epidiolex would be the first pharmaceutical formulation of purified, plant-based CBD, a cannabinoid lacking the high associated with marijuana, and the first in a new category of anti-epileptic drugs (AEDs).

Sterling Pharma will boost its API manufacturing capabilities

api
Contract development and manufacturing organisation Sterling Pharma Solutions is investing £6 million (approximately €6,86 million) into its pilot plant facility at its UK site.

Subscribe to GMP news Newsletter!

Interview

Counterfeit products will even not get into the licensed pharmacy chains

murashko
Russian State Duma adopted a bill on labeling of medicinal products with Data Matrix labels. This procedure will become mandatory from January 1, 2020

National producers entered the market with nearly a dozen of biosimilars

Denis Manturov
Denis Manturov told the correspondent of "Expert" magazine how the Ministry for Industry & Trade continues to work towards technical upgrading of the Russian industry, about current progress in th...

The long and expensive process to enter the international market

Nikolai Yemelianov - Niarmedic Plus
What is the difference between the native antiviral drugs and imported ones and what is necessary for their entry into foreign markets, described the head of the Department of medical research and inf...

Subscribe to GMP news Newsletter!

Magazine

Specialized publication dedicated to Good Manufacturing Practice, modernization of pharmaceutical production, and modern pharmaceutical manufacturing technologies